Class II
Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-039-20
Subpotent and Superpotent Drug
- Recall number
- D-0132-2025
- Report date
- December 18, 2024
- Classification
- Class II
- Status in dataset
- Ongoing
- Recalling firm
- Mylan Institutional, Inc.
- Generic names
- LEVOTHYROXINE SODIUM
- Brand names
- LEVOTHYROXINE SODIUM
- Product NDCs
- 42292-039, 42292-038, 42292-041, 42292-040
Code and lot information
Lot #: 3115707, Exp. Date 02/2025
Distribution
Nationwide in the USA.
Do not stop or change a prescribed medication based only on this page.Contact your pharmacist or prescriber and compare the exact product, manufacturer, NDC, and lot information.
Source and limitations
This page reflects a public openFDA Drug Enforcement record. The dataset was last checked on September 23, 2026. openFDA states that enforcement data should not be used alone to issue public alerts or track the full lifecycle of a recall.
Review the official FDA Drug Recalls page and the underlying openFDA query.